Immunodiagnostic Systems

IDS is a global medical diagnostics business dedicated to the development and provision of innovative automated and manual assays. Our development focus is in the clinical areas of bone and calcium metabolism, growth, hypertension and chronic kidney disease. Our IDS-iSYS system is designed with the flexibility to accommodate unique and challenging requirements, the IDS-iSYS automation brings testing efficiency and uncompromised quality to specialty immunoassay testing. IDS provides a compact bench top system that fully automates immunoassay testing. IDS has its global headquarters in the UK, and has subsidiaries in the USA, Germany, France, and Denmark. Other markets, including key diagnostic markets of Spain, Italy, Australia, and Japan, are serviced by a network of highly qualified and experienced distributors within each territory.
Boldon Colliery, GB
Size (employees)
328 (est)-2%
Immunodiagnostic Systems was founded in 1977 and is headquartered in Boldon Colliery, GB

Immunodiagnostic Systems Office Locations

Immunodiagnostic Systems has offices in Boldon Colliery, Gaithersburg, Paris, Frankfurt and in 1 other locations
Boldon Colliery, GB
Copenhagen, DK
Frankfurt, DE
Paris, FR
Gaithersburg, US

Immunodiagnostic Systems Metrics

Immunodiagnostic Systems Summary

Market capitalization

£82.4 m

Closing share price

Immunodiagnostic Systems's current market capitalization is £82.4 m.

Immunodiagnostic Systems Financials

Immunodiagnostic Systems's revenue is £52.3 m in FY, 2014 which is a 15.2% increase from the previous period.
FY, 2014FY, 2015FY, 2016


£52.3 m£45.4 m£38.3 m

Revenue growth, %


Cost of sales

£16.7 m£17 m£15.8 m

Gross profit

£35.6 m£28.3 m£22.5 m

Gross profit Margin, %


Operating expense total

£27.3 m£25.1 m£59.3 m

Immunodiagnostic Systems Market Value History

Immunodiagnostic Systems Online Presence

Immunodiagnostic Systems Company Life

You may also be interested in